Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma

Disease Sites:

Multiple Myeloma

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Oluwole, Olalekan

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

04-01-2024

Trial Type:

Treatment

Protocol ID:

VICC-XDCTT24033

National Clinical Trial ID:

NCT05346835

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available